Quintiles Transnational Japan and Bushu Pharmaceuticals jointly announced that the two companies have begun developing a business model for production of investigational new drugs. By combining Quintiles’ strength in clinical trial support and Bushu’s experience on investigational drug service, the partners will provide full-range services, aiming to improve the speed and convenience of new drug development.
